CFO and Independent Director resign; new appointments and Q3 results declared

Cfo ResignedKmp ResignedManagement Changes View source PDF Explain this filing

AHCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.4%Reaction day

₹12.68

prior close

₹12.87

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-3.4% vs market

Pharmaceuticals peers, median of 159sector+0.4%-2.9% vs sector

On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250 and 2.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-1.7

15m

-1.7

30m

-2.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.4+1.0-3.4+0.4-2.9

Next day

-3.0+0.5-3.5+0.3-3.3

-3.9-0.0-3.9+0.0-3.9

-4.6-1.5-3.1-1.2-3.4

-4.8-2.2-2.6-1.7-3.1

-3.9-1.2-2.7-1.8-2.2

-7.7-2.4-5.4-2.5-5.2

15d

-14.0-8.8-5.2-6.9-7.1

-1.1-8.3+7.2-5.1+4.0

+2.2-3.5+5.8-3.5+5.7

+12.0+6.4+5.6+2.8+9.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board met on Feb 9, 2026. CFO Hitesh Makwana resigned citing pre-occupation, replaced by Naimish Bhatt with 18 plus years of finance experience. Independent Director Shailesh Thakkar resigned citing health issues, replaced by chartered accountant Kishan Raja. Q3 FY26 revenue fell sharply to Rs 35.58 crore from Rs 71.36 crore YoY, with profit after tax at Rs 5.15 crore versus Rs 9.32 crore. Nine month revenue was Rs 93.25 crore with PAT of Rs 18.02 crore. IPO proceeds of Rs 121.03 crore are on track with Rs 95.79 crore utilized and no deviation reported.

Likely market impact

Top-level management turnover in finance and board. Q3 revenue roughly halved year on year, a concern, though profits stayed positive and IPO spending is on track.